Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

270.24
+2.871.07%
Post-market: 271.000.7600+0.28%19:59 EDT
Volume:6.19M
Turnover:1.67B
Market Cap:651.09B
PE:31.29
High:272.66
Open:267.83
Low:267.00
Close:267.37
52wk High:276.47
52wk Low:173.33
Shares:2.41B
Float Shares:2.40B
Volume Ratio:0.95
T/O Rate:0.26%
Dividend:5.24
Dividend Rate:1.94%
EPS(TTM):8.64
EPS(LYR):11.03
ROE:25.74%
ROA:8.59%
PB:7.66
PE(LYR):24.49

Loading ...

Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)?

Simply Wall St.
·
Jul 24

Ema's Chmp: Recommends Granting Marketing Authorisation for Icotyde

THOMSON REUTERS
·
Jul 24

J&J Names C1do1, Curium Life Tech, Iq Surgical as Polyphonic AI Fund for Surgery Cohort at SRS Meeting

Reuters
·
Jul 23

J&J Says In-development Blood Cancer Treatment Can Reduce Risk of Death, Disease Progression

Dow Jones
·
Jul 23

Johnson & Johnson's Tecvayli, Talvey Phase 3 Study in Relapsed or Refractory Multiple Myeloma Improves Progression-Free Survival

MT Newswires Live
·
Jul 23

Johnson & Johnson Posts Press Release on Monumental-6 Multiple Myeloma Trial Results

Reuters
·
Jul 23

J&J - Monumental-6 Shows Significant Improvements in Progression-free and Overall Survival Versus Standard of Care

THOMSON REUTERS
·
Jul 23

Tecvayli® + Talvey® Reduced the Risk of Disease Progression or Death by 89% and the Risk of Death by 62% in Earlier-line Relapsed/refractory Multiple Myeloma

THOMSON REUTERS
·
Jul 23

J&J - Tecvayli + Talvey Arm Reduces Progression or Death Risk by 89%; Talvey + Pomalidomide by 73%

THOMSON REUTERS
·
Jul 23

Analysts Have Conflicting Sentiments on These Healthcare Companies: Summit Therapeutics (SMMT), Molina Healthcare (MOH) and Johnson & Johnson (JNJ)

TIPRANKS
·
Jul 23

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Helus Pharma (HELP) and Nektar Therapeutics (NKTR)

TIPRANKS
·
Jul 23

US Judge Casts Doubt on 69,000 Cases Alleging J&J Talc Caused Cancer

Reuters
·
Jul 23

Johnson & Johnson Continues Recovery After Green Light Given to ‘Next Era’ Robotic Surgeon

TIPRANKS
·
Jul 22

J&J Climbs After Receiving FDA Authorization for Surgical Robot

Reuters
·
Jul 22

Johnson & Johnson’s robotic surgery device gets US marketing authorization

Bloomberg
·
Jul 22

Johnson & Johnson Innovation to Host Virtual Pitch Session for Oral Peptide Delivery Challenge Finalists

Reuters
·
Jul 22

Johnson & Johnson's Robotic Surgery Device Gets US FDA Marketing Authorization

Reuters
·
Jul 22

Johnson & Johnson Receives FDA Market Authorization in the U.S. for Its Ottava™ Robotic Surgical System

THOMSON REUTERS
·
Jul 22

J&J - U.S. Clinical Trial for Ottava in Inguinal Hernia Procedures Ongoing

THOMSON REUTERS
·
Jul 22

Rockwell Medical Names Brian Cox VP, Quality and Regulatory Compliance

Reuters
·
Jul 22